Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOICE UTI
NCT04876131Phase 4Recruiting
- Sponsor
- Murdoch Children's Research Institute
- Start
- May 2022
- Primary completion
- Jan 2028
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 2
01
Overview
A Phase 4 trial of gentamicin, benzylpenicillin in complicated urinary tract infection (cUTI), sponsored by Murdoch Children's Research Institute. Started May 2022; status: recruiting.
02
Drugs
gentamicinbenzylpenicillin
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT04876131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04876131.